Who are Brainsway's investors?

Brainsway's investors include Valor Equity Partners.

How much funding has Brainsway raised?

Brainsway has disclosed $20M raised across 1 round.

Where is Brainsway headquartered?

Brainsway is headquartered in Jerusalem, US.

Brainsway

Jerusalem, US · Israel corporation · 1 known investors

Find your way into Brainsway

Paths you didn't know you had: your email and LinkedIn already hold routes to the Brainsway team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

BrainsWay develops Deep TMS (Transcranial Magnetic Stimulation) systems for treating psychiatric and neurological conditions including depression, OCD, and smoking addiction. The platform includes brain-targeting stimulators with patented H-Coils, patient management capabilities, and clinical research-grade variants for healthcare providers.

Biotech Digital Health Healthtech Medical Devices Mental Health

Founders & leadership

Hadar LevyChief Executive OfficerHe previously held leadership roles at GE Healthcare, Amdocs, and Notal Vision, and has been with BrainsWay for over a decade, overseeing commercial initiatives including M&A, fundraising, and the company's Nasdaq listing.

Ido MaromCFO

Abraham ZangenNamed on SEC filing

Board

Yossi Ben ShalomBoard director

Avner HagaiBoard director

David ZacutVice Chairman of the Board of Directors

Eti MitranyBoard director

Karen SaridBoard director

Ami BoehmChairman of the Board of Directors

Avner LushiBoard director

Investors · 1

Valor Equity Partnerslisted by Valor Equity PartnersChicago

How we know: Valor Equity Partners's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$20M disclosed across 1 round · 2024

▶$20MraisedOct 2024 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Hadar LevyExecutive Officer
Yossi Ben ShalomDirector
Avner HagaiDirector
David ZacutDirector
Ido MaromExecutive Officer
Abraham ZangenDirector
Eti MitranyDirector
Karen SaridDirector
Ami BoehmDirector
Avner LushiDirector

Offering amount: $20M
Amount sold: $20M
First sale: Sep 2024
Incorporated: Corporation, Israel
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

PsychcentralPsych Central is a digital publisher providing informational content on mental health, wellness, and medical topics developed in collaboration with licensed medical professionals. The company serves general audiences seeking educational resources on health conditions and treatments.

Companies working in the same space as Brainsway.

Frequently asked questions

What does Brainsway do?: BrainsWay develops Deep TMS (Transcranial Magnetic Stimulation) systems for treating psychiatric and neurological conditions including depression, OCD, and smoking addiction. The platform includes brain-targeting stimulators with patented H-Coils, patient management capabilities, and clinical research-grade variants for healthcare providers.
Who are Brainsway's investors?: Brainsway's investors include Valor Equity Partners.
How much funding has Brainsway raised?: Brainsway has disclosed $20M raised across 1 round.
Where is Brainsway headquartered?: Brainsway is headquartered in Jerusalem, US.